Find a Doctor
Performs botox for chronic migraine and lumbar puncture procedures
Board certified in headache medicine
Kerry Knievel, DO, is a neurologist, professor of neurology, and director of the Lewis Headache Center at Barrow Neurological Institute. She is licensed through the Arizona Board of Osteopathic Medical Examiners and board certified in neurology by the American Board of Psychiatry and Neurology and in headache medicine by the United Council for Neurologic Subspecialties.
Dr. Knievel’s areas of interest include headaches and neuromuscular diseases. She is a member of the American Academy of Neurology, American Headache Society, and American Association of Neuromuscular and Electrodiagnostic Medicine.
Dr. Knievel received her Doctorate of Osteopathic Medicine from Kirksville College of Osteopathic Medicine in Kirksville, Missouri. She completed her residency in neurology at Barrow Neurological Institute, where she also completed a neuromuscular fellowship.
For more information or to request an appointment, please call (602) 406-6262.
Fax: (602) 406-6261
- Aetna
- AHCCS (Referral Required)
- Blue Cross Blue Shield
- Blue Cross Blue Shield Third Party
- Cigna
- Commercial Networks
- Government Plans
- Humana
- Market Place Plans (Referral Required)
- Medicare Advantage Plans (Referral Required)
- United Healthcare
- Board certified in Neurology, headache medicine, and neuromuscular medicine
- Fellowship, Barrow Neurological Institute, Neuromuscular Diseases, EMG, 2011-2012
- Residency, Barrow Neurological Institute, Neurology, 2008-2011
- Internship, St. Joseph’s Hospital and Medical Center, 2007-2008
- DO, Kirksville College of Osteopathic Medicine, with honors, 2007
- MS, Colorado State University, Anatomy and Neurobiology, 2002
- BS, Colorado State University, Biological Science, magna cum laude, 2001
- Board member of the Headache Cooperative of the Pacific, member of the International Headache Society
- President of the Arizona Neurological society
- American Academy of Neurology
- American Headache Society
- Creighton University teacher of the year, 2015
- CSF Leak Foundation Grant: quantitative thecal sac volume and morphology as a diagnostic tool in intracranial hypotension, 2018
Can Long-Term Outcomes of Posttraumatic Headache be Predicted?
Date: 05/2024
Authors: Olivia Kingsford, Mustafa Yehya, Glynnis Zieman, Kerry L Knievel
Lasmiditan for the acute treatment of migraine: Subgroup analyses by prior response to triptans.
Date: 01/2020
Authors: Kerry Knievel, Andrew S Buchanan, Louise Lombard, Simin Baygani, Joel Raskin, John H Krege, Li Shen Loo, Mika Komori, Joshua Tobin
Long-Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine: Phase 3, Randomized, 52-Week Extension Trial.
Date: 01/2020
Authors: Jessica Ailani, Richard B Lipton, Susan Hutchinson, Kerry Knievel, Kaifeng Lu, Matthew Butler, Sung Yun Yu, Michelle Finnegan, Lawrence Severt, Joel M Trugman
Incidence and Predictors of Dural Venous Sinus Pressure Gradient in Idiopathic Intracranial Hypertension and Non-Idiopathic Intracranial Hypertension Headache Patients: Results From 164 Cerebral Venograms
Date: 01/2017
Authors: Michael R. Levitt, Randall J. Hlubek, Karam Moon, M. Yashar Kalani, M Yashar Kalani, Peter Nakaji, P. Nakaji, Kris A Smith, Andrew S Little, Kerry Knievel, Jane W. Chan, Cameron G. McDougall, Felipe C. Albuquerque
Use of Intracranial Pressure Monitoring Frequently Refutes Diagnosis of Idiopathic Intracranial Hypertension
Date: 01/2017
Authors: David S. Xu, Randall J. Hlubek, Celene B. Mulholland, Kerry Knievel, Kris A. Smith, Peter Nakaji
- English
Performs botox for chronic migraine and lumbar puncture procedures
Board certified in headache medicine
Kerry Knievel, DO, is a neurologist, professor of neurology, and director of the Lewis Headache Center at Barrow Neurological Institute. She is licensed through the Arizona Board of Osteopathic Medical Examiners and board certified in neurology by the American Board of Psychiatry and Neurology and in headache medicine by the United Council for Neurologic Subspecialties.
Dr. Knievel’s areas of interest include headaches and neuromuscular diseases. She is a member of the American Academy of Neurology, American Headache Society, and American Association of Neuromuscular and Electrodiagnostic Medicine.
Dr. Knievel received her Doctorate of Osteopathic Medicine from Kirksville College of Osteopathic Medicine in Kirksville, Missouri. She completed her residency in neurology at Barrow Neurological Institute, where she also completed a neuromuscular fellowship.
For more information or to request an appointment, please call (602) 406-6262.
Fax: (602) 406-6261
- Aetna
- AHCCS (Referral Required)
- Blue Cross Blue Shield
- Blue Cross Blue Shield Third Party
- Cigna
- Commercial Networks
- Government Plans
- Humana
- Market Place Plans (Referral Required)
- Medicare Advantage Plans (Referral Required)
- United Healthcare
- Board certified in Neurology, headache medicine, and neuromuscular medicine
- Fellowship, Barrow Neurological Institute, Neuromuscular Diseases, EMG, 2011-2012
- Residency, Barrow Neurological Institute, Neurology, 2008-2011
- Internship, St. Joseph’s Hospital and Medical Center, 2007-2008
- DO, Kirksville College of Osteopathic Medicine, with honors, 2007
- MS, Colorado State University, Anatomy and Neurobiology, 2002
- BS, Colorado State University, Biological Science, magna cum laude, 2001
- Board member of the Headache Cooperative of the Pacific, member of the International Headache Society
- President of the Arizona Neurological society
- American Academy of Neurology
- American Headache Society
- Creighton University teacher of the year, 2015
- CSF Leak Foundation Grant: quantitative thecal sac volume and morphology as a diagnostic tool in intracranial hypotension, 2018
Can Long-Term Outcomes of Posttraumatic Headache be Predicted?
Date: 05/2024
Authors: Olivia Kingsford, Mustafa Yehya, Glynnis Zieman, Kerry L Knievel
Lasmiditan for the acute treatment of migraine: Subgroup analyses by prior response to triptans.
Date: 01/2020
Authors: Kerry Knievel, Andrew S Buchanan, Louise Lombard, Simin Baygani, Joel Raskin, John H Krege, Li Shen Loo, Mika Komori, Joshua Tobin
Long-Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine: Phase 3, Randomized, 52-Week Extension Trial.
Date: 01/2020
Authors: Jessica Ailani, Richard B Lipton, Susan Hutchinson, Kerry Knievel, Kaifeng Lu, Matthew Butler, Sung Yun Yu, Michelle Finnegan, Lawrence Severt, Joel M Trugman
Incidence and Predictors of Dural Venous Sinus Pressure Gradient in Idiopathic Intracranial Hypertension and Non-Idiopathic Intracranial Hypertension Headache Patients: Results From 164 Cerebral Venograms
Date: 01/2017
Authors: Michael R. Levitt, Randall J. Hlubek, Karam Moon, M. Yashar Kalani, M Yashar Kalani, Peter Nakaji, P. Nakaji, Kris A Smith, Andrew S Little, Kerry Knievel, Jane W. Chan, Cameron G. McDougall, Felipe C. Albuquerque
Use of Intracranial Pressure Monitoring Frequently Refutes Diagnosis of Idiopathic Intracranial Hypertension
Date: 01/2017
Authors: David S. Xu, Randall J. Hlubek, Celene B. Mulholland, Kerry Knievel, Kris A. Smith, Peter Nakaji
- English